DPAGT1 and tuberculosis: These analogues show nanomolar antimicrobial potency, ablated inhibition of DPAGT1, much reduced toxicity, allowed effective treatment of Mycobacterium tuberculosis (Mtb) in mammals, providing leads for tuberculosis (TB) antibiotic development.